Among the 1200 patients who underwent tumor exome analysis, we found a total of 141 patients (representing 11.75% of the screened population) with PIK3CA or PIK3R1 somatic mutation (Supplemental Fig. 1). This evidence concerns the gene PIK3CA and neoplasm.